Hypernasality associated with basal ganglia dysfunction: evidence from Parkinson's disease and Huntington's disease
Status PubMed-not-MEDLINE Jazyk angličtina Země Spojené státy americké Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
27703866
PubMed Central
PMC5047145
DOI
10.7717/peerj.2530
PII: 2530
Knihovny.cz E-zdroje
- Klíčová slova
- 1/3-octave spectra, Acoustic analysis, Dysarthria, Huntington Disease, Nasality, Parkinson Disease, Speech disorders,
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Although increased nasality can originate from basal ganglia dysfunction, data regarding hypernasality in Parkinson's disease (PD) and Huntington's disease (HD) are very sparse. The aim of the current study was to analyze acoustic and perceptual correlates of velopharyngeal seal closure in 37 PD and 37 HD participants in comparison to 37 healthy control speakers. METHODS: Acoustical analysis was based on sustained phonation of the vowel /i/ and perceptual analysis was based on monologue. Perceptual analysis was performed by 10 raters using The Great Ormond Street Speech Assessment '98. Acoustic parameters related to changes in a 1/3-octave band centered on 1 kHz were proposed to reflect nasality level and behavior through utterance. RESULTS: Perceptual analysis showed the occurrence of mild to moderate hypernasality in 65% of PD, 89% of HD and 22% of control speakers. Based on acoustic analyses, 27% of PD, 54% of HD and 19% of control speakers showed an increased occurrence of hypernasality. In addition, 78% of HD patients demonstrated a high occurrence of intermittent hypernasality. Further results indicated relationships between the acoustic parameter representing fluctuation of nasality and perceptual assessment (r = 0.51, p < 0.001) as well as the Unified Huntington Disease Rating Scale chorea composite subscore (r = 0.42, p = 0.01). CONCLUSIONS: In conclusion the acoustic assessment showed that abnormal nasality was not a common feature of PD, whereas patients with HD manifested intermittent hypernasality associated with chorea.
Zobrazit více v PubMed
Brancewicz TM, Reich AR. Speech rate reduction and “nasality” in normal speakers. Journal of Speech and Hearing Research. 1989;32:837–848. doi: 10.1044/jshr.3204.837. PubMed DOI
Chenery HJ, Murdoch BE, Ingram JCL. Studies in Parkinson’s disease: I. Perceptual speech analyses. Australian Journal of Human Communication Disorders. 1988;16:17–29. doi: 10.3109/asl2.1988.16.issue-2.02. DOI
Couvreour C. Implementation of a one-third-octave filter bank in MATLAB. Mons: Faculte Polytechnique de Mons; 1998. pp. 1–12.
Darley FL, Aronson AE, Brown JR. Motor speech disorders. WB Saunders; Philadephia: 1975.
Dickson DR. An acoustic study of nasality. Journal of Speech and Hearing Research. 1962;5:103–111. doi: 10.1044/jshr.0502.103. PubMed DOI
Dillenschneider E, Zaleski T, Greiner GF. Sonagraphic study of nasality in cases of palatovelar insufficiency. JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac. 1973;22:201–202. PubMed
Duffy JR. Motor speech disorders: substrates, differential diagnosis, and management. Elsevier Health Sciences; St. Louis: 2013.
Fant G. Acoustic theory of speech production: with calculations based on X-ray studies of Russian articulations. The Hague; Mouton: 1960.
Folkins JW. Velopharyngeal nomenclature: incompetence, inadequacy, insufficiency, and dysfunction. The Cleft Palate Journal. 1988;25:413–416. PubMed
Hardin MA, Vandemark DR, Morris HL, Payne MM. Correspondence between nasalance scores and listener judgments of hypernasality and hyponasality. Cleft Palate-Craniofacial Journal. 1992;29:346–351. doi: 10.1597/1545-1569(1992)029<0346:CBNSAL>2.3.CO;2. PubMed DOI
Hartelius L, Carlstedt A, Ytterberg M, Lillvik M, Laakso K. Speech disorders in mild and moderate Huntington disease: results of dysarthria assessments of 19 individuals. Journal of Medical Speech-Language Pathology. 2003;11:1–14.
Hirose H, Kiritani S, Ushijima T, Yoshioka H, Sawashima M. Patterns of dysarthric movements in patients with Parkinsonism. Folia Phoniatr. 1981;33:204–215. doi: 10.1159/000265595. PubMed DOI
Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427–442. doi: 10.1212/WNL.17.5.427. PubMed DOI
Hoit JD, Watson PJ, Hixon KE, Mcmahon P, Johnson CL. Age and velopharyngeal function during speech production. Journal of Speech and Hearing Research. 1994;37:295–302. doi: 10.1044/jshr.3702.295. PubMed DOI
Hoodin RB, Gilbert HR. Nasal airflows in parkinsonian speakers. Journal of Communication Disorders. 1989;22:169–180. doi: 10.1016/0021-9924(89)90014-2. PubMed DOI
Horii Y. An accelerometric approach to nasality measurement—a preliminary-report. Cleft Palate Journal. 1980;17:254–261. PubMed
Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study. Neurology. 1992;42:1142–1146. doi: 10.1212/WNL.42.6.1142. PubMed DOI
Huntington-Study-Group Unified Huntington’s disease rating scale: reliability and consistency. Movement Disorders. 1996;11:136–142. doi: 10.1002/mds.870110204. PubMed DOI
Jankovic J. Parkinson’s disease: clinical features and diagnosis. Journal of Neurology, Neurosurgery and Psychiatry. 2008;79:368–376. doi: 10.1136/jnnp.2007.131045. PubMed DOI
Joos U, Wermker K, Kruse-Loesler B, Kleinheinz J. Influence of treatment concept, velopharyngoplasty, gender and age on hypernasality in patients with cleft lip, alveolus and palate. Journal of Cranio-Maxillofacial Surgery. 2006;34:472–477. doi: 10.1016/j.jcms.2006.07.858. PubMed DOI
Kataoka R, Michi K, Okabe K, Miura T, Yoshida H. Spectral properties and quantitative evaluation of hypernasality in vowels. Cleft Palate-Craniofacial Journal. 1996;33:43–50. doi: 10.1597/1545-1569(1996)033<0043:SPAQEO>2.3.CO;2. PubMed DOI
Kempster GB, Gerratt BR, Abbott KV, Barkmeier-Kraemer J, Hillman RE. Consensus auditory-perceptual evaluation of voice: development of a standardized clinical protocol. American Journal of Speech-Language Pathology. 2009;18:124–132. doi: 10.1044/1058-0360(2008/08-0017). PubMed DOI
Kent RD, Weismer G, Kent JF, Vorperian HK, Duffy JR. Acoustic studies of dysarthric speech: methods, progress, and potential. Journal of Communication Disorders. 1999;32:141–186. doi: 10.1016/S0021-9924(99)00004-0. PubMed DOI
Kuehn DP, Moller KT. The state of the art: speech and language issues in the cleft palate population. Cleft Palate-Craniofacial Journal. 2000;37:348–348. doi: 10.1597/1545-1569(2000)037<0348:SALIIT>2.3.CO;2. DOI
Lee AS, Ciocca V, Whitehill TL. Acoustic correlates of hypernasality. Clinical Linguistics & Phonetics. 2003;17:259–264. doi: 10.1080/0269920031000080091. PubMed DOI
Litzaw LL, Dalston RM. The effect of gender upon nasalance scores among normal adult speakers. Journal of Communication Disorders. 1992;25:55–64. doi: 10.1016/0021-9924(92)90014-N. PubMed DOI
Logemann JA, Fisher HB, Boshes B, Blonsky ER. Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. Journal of Speech and Hearing Disorders. 1978;43:47–57. doi: 10.1044/jshd.4301.47. PubMed DOI
Ludlow CL, Basich CJ. The results of acoustic and perceptual assessment of two types of dysarthria. In: Berry WR, editor. Clinical dysarthria. College-Hill Press; San Diego: 1983. pp. 121–154.
Maier A, Schuster M, Haderlein T, Noth E. Hypernasality in speech of children with cleft lip and palate: automatic evaluation 8th international seminar on speech production, Strasbourg. 2008. pp. 277–280.
Mueller PB. Parkinson’s disease: motor-speech behavior in a selected group of patients. Folia Phoniatr. 1971;23:333–346. doi: 10.1159/000263516. PubMed DOI
Netsell R, Daniel B, Celesia GG. Acceleration and weakness in Parkinsonian dysarthria. Journal of Speech and Hearing Disorders. 1975;40:170–178. doi: 10.1044/jshd.4002.170. PubMed DOI
Poole ML, Wee JS, Folker JE, Corben LA, Delatycki MB, Vogel AP. Nasality in Friedreich ataxia. Clinical Linguistics & Phonetics. 2015;29:46–58. doi: 10.3109/02699206.2014.954734. PubMed DOI
Ramig LA, Ringel RL. Effects of physiological aging on selected acoustic characteristics of voice. Journal of Speech and Hearing Research. 1983;26:22–30. doi: 10.1044/jshr.2601.22. PubMed DOI
Rusz J, Cmejla R, Ruzickova H, Ruzicka E. Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson’s disease. Journal of the Acoustical Society of America. 2011;129:350–367. doi: 10.1121/1.3514381. PubMed DOI
Rusz J, Klempir J, Baborova E, Tykalova T, Majerova V, Cmejla R, Ruzicka E, Roth J. Objective acoustic quantification of phonatory dysfunction in Huntington’s disease. PLoS ONE. 2013;8:e2530. doi: 10.1371/journal.pone.0065881. PubMed DOI PMC
Rusz J, Klempir J, Tykalova T, Baborova E, Cmejla R, Ruzicka E, Roth J. Characteristics and occurrence of speech impairment in Huntington’s disease: possible influence of antipsychotic medication. Journal of Neural Transmission. 2014;121:1529–1539. doi: 10.1007/s00702-014-1229-8. PubMed DOI
Rusz J, Tykalova T, Klempir J, Cmejla R, Ruzicka E. Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson’s disease: longitudinal follow-up study on previously untreated patients. Journal of Neural Transmission. 2016;123:379–387. doi: 10.1007/s00702-016-1515-8. PubMed DOI
Schlesinger MI, Hlavac V. Ten lectures on statistical and structural pattern recognition. Kluwer Academic Press; Dordrecht: 2002.
Schulz GM, Grant MK. Effects of speech therapy and pharmacologic and surgical treatments on voice and speech in Parkinson’s disease: a review of the literature. Journal of Communication Disorders. 2000;33:59–88. doi: 10.1016/S0021-9924(99)00025-8. PubMed DOI
Sell D, Harding A, Grunwell P. GOS.SP.ASS.’98: an assessment for speech disorders associated with cleft palate and/or velopharyngeal dysfunction (revised) International Journal of Language & Communication Disorders. 1999;34:17–33. doi: 10.1080/136828299247595. PubMed DOI
Skodda S, Schlegel U, Hoffmann R, Saft C. Impaired motor speech performance in Huntington’s disease. Journal of Neural Transmission. 2014;121:399–407. doi: 10.1007/s00702-013-1115-9. PubMed DOI
Stebbins GT, Goetz CG. Factor structure of the Unified Parkinson’s Disease Rating Scale: motor examination section. Movement Disorders. 1998;13:633–636. doi: 10.1002/mds.870130404. PubMed DOI
Stevens KN. Acoustic phonetics. The MIT Press; Cambridge: 2000.
Theodoros DG, Murdoch BE, Thompson EC. Hypernasality in Parkinson disease: a perceptual and physiological analysis. Journal of Medical Speech-Language Pathology. 1995;3:73–84.
Titze IR. Workshop on acoustic voice analysis. National Center for Speech and Voice; Denver: 1994. Workshop on acoustic voice analysis.
Vogel AP, Ibrahim HM, Reilly S, Kilpatrick N. A comparative study of two acoustic measures of hypernasality. Journal of Speech Language and Hearing Research. 2009;52:1640–1651. doi: 10.1044/1092-4388(2009/08-0161). PubMed DOI
Walker FO. Huntington’s disease. Lancet. 2007;369:218–228. doi: 10.1016/S0140-6736(07)60111-1. PubMed DOI
Warren DW, Dalston RM, Mayo R. Hypernasality in the presence of adequate velopharyngeal closure. Cleft Palate-Craniofacial Journal. 1993;30:150–154. doi: 10.1597/1545-1569(1993)030<0150:HITPOA>2.3.CO;2. PubMed DOI
Yoshida H, Furuya Y, Shimodaira K, Kanazawa T, Kataoka R, Takahashi K. Spectral characteristics of hypernasality in maxillectomy patients. Journal of Oral Rehabilitation. 2000;27:723–730. doi: 10.1046/j.1365-2842.2000.00537.x. PubMed DOI